Cold-Pressed Canola Oil (Brassica napus)

Cold-pressed canola oil retains bioactive polyphenols, tocopherols, and phytosterols removed during conventional refining, which may support cardiovascular health through LDL cholesterol reduction and antioxidant activity. Its high oleic acid content (approximately 61%) interacts with lipid metabolism pathways, while preserved sinapic acid and other phenolic compounds contribute to oxidative stress reduction.

Origin & History

Cold-pressed canola oil is extracted from the seeds of Brassica napus (low-erucic-acid rapeseed variety), a plant in the Brassicaceae family related to cabbage and turnips. The oil is mechanically pressed from cleaned, pre-heated seeds below 49°C/120°F without chemical solvents, preserving natural compounds including phenolics, tocopherols, and phytosterols compared to refined oils.

Historical & Cultural Context

No historical or traditional medicinal uses of cold-pressed canola oil are documented, as it is primarily a modern edible oil developed from rapeseed breeding in the 1970s for low erucic acid content. While rapeseed has been cultivated for oil since ancient times, therapeutic contexts in traditional medicine systems are not referenced.

Health Benefits

• May support blood lipid regulation through preserved bioactive compounds (preliminary evidence only, no human trials identified)
• Potential insulin sensitivity and glycemic control benefits inferred from oil quality reviews (no direct clinical evidence)
• Antioxidant effects from retained phenolic compounds like canolol and tocopherols (compositional studies only)
• May provide cytotoxic effects against certain cell lines (preclinical evidence only)
• Higher retention of beneficial compounds compared to refined oils due to cold-pressing process (compositional analysis)

How It Works

Cold-pressed canola oil's oleic acid (C18:1) modulates LDL receptor upregulation in hepatocytes, reducing circulating LDL-cholesterol concentrations. Retained phytosterols, primarily beta-sitosterol and campesterol, competitively inhibit cholesterol absorption at intestinal brush-border membranes via NPC1L1 transporter interference. Phenolic compounds such as sinapic acid and canolol scavenge reactive oxygen species and may inhibit NF-kB inflammatory signaling, though these mechanisms remain largely demonstrated in vitro or in animal models rather than confirmed human trials.

Scientific Research

No human clinical trials, RCTs, or meta-analyses specifically on cold-pressed canola oil were identified in the research. Evidence is limited to preclinical and compositional studies, with health claims inferred from preserved bioactive compounds rather than direct human trials.

Clinical Summary

No published human clinical trials have specifically isolated cold-pressed canola oil as the intervention; existing evidence is extrapolated from conventional canola oil studies and oil quality reviews. Randomized controlled trials on conventional canola oil in cohorts of 30–100 subjects have reported LDL reductions of approximately 8–15% compared to saturated fat controls, though cold-pressed variants are assumed to deliver superior effects due to higher retained bioactives. Animal studies using phenolic-rich canola oil preparations have shown improved insulin sensitivity markers, but direct translation to human outcomes is unconfirmed. Overall evidence quality is low-to-moderate and specific to cold-pressed processing is preliminary at best.

Nutritional Profile

Cold-pressed canola oil (Brassica napus) is a pure fat source providing approximately 884 kcal per 100g (3.7 MJ/100g). Macronutrient composition is ~100g total fat per 100g with negligible protein, carbohydrate, and fiber. Fatty acid profile per 100g: monounsaturated fats ~61–65g (predominantly oleic acid, C18:1 omega-9 at ~58–62g); polyunsaturated fats ~28–32g (linoleic acid C18:2 omega-6 at ~18–22g; alpha-linolenic acid C18:3 omega-3 at ~9–11g, yielding an omega-6:omega-3 ratio of approximately 2:1); saturated fats ~6–7g (palmitic acid C16:0 ~4g, stearic acid C18:0 ~2g). Erucic acid (C22:1) is <2% by regulatory standard in commercial cultivars, typically <0.5% in modern varieties. Micronutrients: Vitamin E (tocopherols) ~17–22mg per 100g, predominantly gamma-tocopherol (~38–50% of total tocopherols) and alpha-tocopherol (~25–30%); vitamin K1 (phylloquinone) ~71–72 mcg per 100g. Bioactive compounds uniquely elevated in cold-pressed versus refined canola oil: canolol (2,6-dimethoxy-4-vinylphenol) at ~200–1500 mg/kg depending on roasting pretreatment and cultivar — a potent phenolic antioxidant largely destroyed by conventional refining; total phenolic content ~20–120 mg sinapic acid equivalents per kg; sinapic acid and sinapine derivatives present at trace-to-low levels. Phytosterols: ~700–900 mg per 100g, primarily beta-sitosterol (~50%), campesterol (~30%), and brassicasterol (~10–15%), the latter being a characteristic marker of Brassica-origin oils; phytosterol bioavailability is estimated at 5–10% of consumed dose but exerts cholesterol-lowering effects at luminal level. Phospholipids: ~100–200 mg per 100g retained in cold-pressed oil (versus near-zero in refined), including phosphatidylcholine and phosphatidylethanolamine fractions. Chlorophylls: ~1–10 mg per 100g (predominantly pheophytin a), contributing green tint; these are largely absent in refined oil. Carotenoids: trace levels (~0.5–2 mg per 100g as beta-carotene equivalents). Glucosinolate breakdown products (isothiocyanates): present at very low residual levels in oil phase, with the aqueous/solid phase containing the majority; not considered a significant oil-phase constituent. Bioavailability notes: Alpha-linolenic acid (ALA) bioconversion to EPA is approximately 5–10% and to DHA <1% in adults, limiting omega-3 functionality relative to marine sources. Fat-soluble vitamins (E, K) and phytosterols are well-absorbed when consumed with a meal. Canolol demonstrates high in vitro antioxidant activity (DPPH radical scavenging IC50 reported at ~15–30 µM) and moderate bioavailability in rodent models; human pharmacokinetic data are limited to one pilot study suggesting detectable plasma levels post-ingestion. The retained phospholipid and phenolic matrix in cold-pressed oil confers measurably greater oxidative stability compared to refined canola oil under ambient storage, with peroxide values remaining lower over equivalent storage periods.

Preparation & Dosage

No clinically studied dosage ranges for cold-pressed canola oil were identified, as human trials are absent from available research. Studies focus on extraction yields rather than therapeutic dosing, with no standardization specified for clinical use. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Vitamin E, omega-3 fatty acids, phytosterol complexes, antioxidant blends, polyphenol extracts

Safety & Interactions

Cold-pressed canola oil is generally recognized as safe for most adults when consumed in typical dietary amounts of 1–2 tablespoons per day, with no documented serious adverse effects at these levels. Individuals on warfarin or other anticoagulants should exercise caution, as vitamin K content and omega-3 fatty acids (approximately 9% ALA) may modestly influence clotting parameters. Those with Brassica plant allergies should consult a healthcare provider before use, as trace proteins may persist in cold-pressed versus fully refined oils. Pregnant and breastfeeding women are generally considered safe using food-level quantities, though high supplemental doses have not been studied in these populations.